BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23495048)

  • 1. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.
    Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T
    Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
    Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S
    Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular response to latent TGF-beta1 is facilitated by insulin-like growth factor-II/mannose-6-phosphate receptors on MS-9 cells.
    Ghahary A; Tredget EE; Mi L; Yang L
    Exp Cell Res; 1999 Aug; 251(1):111-20. PubMed ID: 10438576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
    Xie S; Kang JX
    Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mannose-6-phosphate on receptor-mediated endocytosis of insulin-like growth factor-II.
    Polychronakos C; Guyda HJ; Janthly U; Posner BI
    Endocrinology; 1990 Oct; 127(4):1861-6. PubMed ID: 2169404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor II/mannose 6-phosphate-receptor expression in liver and serum during acute CCl4 intoxication in the rat.
    De Bleser PJ; Scott CD; Niki T; Xu G; Wisse E; Geerts A
    Hepatology; 1996 Jun; 23(6):1530-7. PubMed ID: 8675174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
    De Leon DD; Terry C; Asmerom Y; Nissley P
    Endocrinology; 1996 May; 137(5):1851-9. PubMed ID: 8612524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system.
    Hawkes C; Kar S
    Brain Res Brain Res Rev; 2004 Mar; 44(2-3):117-40. PubMed ID: 15003389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
    Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
    Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
    Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
    Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-2/mannose-6 phosphate receptors.
    El-Shewy HM; Luttrell LM
    Vitam Horm; 2009; 80():667-97. PubMed ID: 19251055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the IGF axis components in isolated rat hepatic stellate cells.
    Scharf JG; Knittel T; Dombrowski F; Müller L; Saile B; Braulke T; Hartmann H; Ramadori G
    Hepatology; 1998 May; 27(5):1275-84. PubMed ID: 9581681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
    Confort C; Rochefort H; Vignon F
    Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of chondrocyte cathepsin B and L activities by insulin-like growth factor-II (IGF-II) and its Ser29 variant in vitro: possible role of the mannose 6-phosphate/IGF-II receptor.
    De Ceuninck F; Poiraudeau S; Pagano M; Tsagris L; Blanchard O; Willeput J; Corvol M
    Mol Cell Endocrinol; 1995 Sep; 113(2):205-13. PubMed ID: 8674828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol consumption decreases the synthesis of the mannose 6-phosphate/insulin-like growth factor II receptor but does not decrease its messenger RNA.
    Haorah J; MacDonald RG; Stoner JA; Donohue TM
    Biochem Pharmacol; 2003 Feb; 65(4):637-48. PubMed ID: 12566093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mannose-6-phosphate/insulin-like growth factor II receptor expression and tumor development.
    Hébert E
    Biosci Rep; 2006 Feb; 26(1):7-17. PubMed ID: 16779663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.
    Lee JS; Weiss J; Martin JL; Scott CD
    Int J Cancer; 2003 Nov; 107(4):564-70. PubMed ID: 14520693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
    Mathieu M; Vignon F; Capony F; Rochefort H
    Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missorting of cathepsin B into the secretory compartment of CI-MPR/IGFII-deficient mice does not induce spontaneous trypsinogen activation but leads to enhanced trypsin activity during experimental pancreatitis--without affecting disease severity.
    Meister T; Niehues R; Hahn D; Domschke W; Sendler M; Lerch MM; Schnekenburger J
    J Physiol Pharmacol; 2010 Oct; 61(5):565-75. PubMed ID: 21081800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.